Clear market notes built around the JSE, the rand, and what matters locally.

2026-08-26 10:30 • The Motley Fool Positive Axe Cap view: Selective

Billionaire hedge fund manager David Tepper sold all 90,000 shares of UnitedHealth in Q2 to concentrate on AI investments. While medical cost pressures from GLP-1 drugs and inflation are real concerns, the article argues Tepper may have made a mistake, as UnitedHealth is actively managing costs through AI automation, workflow improvements, and strategic GLP-1 coverage policies. The company's operating margins improved and earnings growth remains strong, suggesting it's adapting well to healthcare industry changes.

Axe note: David Tepper’s sale of UnitedHealth shares hints at a bet on AI over healthcare’s traditional winners.

2026-08-26 10:20 • The Motley Fool Neutral Axe Cap view: Neutral

SpaceX announced a $100 billion investment in a new Starship spaceport in Louisiana spanning 125,000 acres with five launch complexes and 3,000 promised jobs, with construction beginning in 2027. While the company shows strong revenue growth ($7.8B in Q2 2026, up 92% YoY) and Starlink subscriber doubling, investors face concerns about massive capital expenditures ($28.5B in H1 2026) and whether Starship's commercial viability will justify the spending.

Axe note: A massive SpaceX spaceport investment signals growth but warns of heavy spending and uncertain returns.

2026-08-26 10:20 • The Motley Fool Positive Axe Cap view: Selective

Billionaire hedge fund manager Ken Griffin's Citadel increased its stake in AbbVie by 547% in Q2, adding 2.7 million shares worth approximately $798 million. The move reflects a defensive investment strategy into a stable dividend stock. AbbVie, a Dividend King with 54 consecutive years of dividend increases, currently yields 2.6% and has 75% of Wall Street analysts rating it as a buy with a median price target of $282.50.

Axe note: Citadel’s massive stake ramp-up in AbbVie underscores demand for reliable dividend income amid global uncertainty.